HIGH
Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.
Labeling: Incorrect or Missing Lot and/or Exp Date
STAQ Pharma
Labeling: Incorrect
HIGH
AFCO Hand Sanitizer Recalled Due to Methanol Risk
AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.
Quick Facts at a Glance
- Recall Date
- September 29, 2025
- Hazard Level
- HIGH
- Brand
- AFCO
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
Hazard Information
cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Acuity Specialty Products, Inc. or your healthcare provider for guidance. Notification method: Letter
Product Details
The recalled product is AFCO Hand Sanitizer, Product 5515. It is available in several configurations: 4x1 gallon cases, 5-gallon pails, and 55-gallon drums. The affected lot numbers include C2432725, C2508304, and C2509304 with expiration dates ranging from November 22, 2025, to April 3, 2026.
The Hazard
The recall stems from cGMP deviations, meaning the required testing for incoming alcohol components was not conducted. This raises the risk of methanol contamination, which can be harmful if ingested or absorbed through the skin.
Reported Incidents
No specific incidents or injuries have been reported related to this recall. However, the potential risks associated with methanol exposure are significant.
What to Do
Consumers should immediately cease use of the recalled hand sanitizer. Contact Acuity Specialty Products at 800-345-1329 for guidance and possible returns.
Contact Information
For more information, visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0005-2026.
Key Facts
- Recalls initiated on September 29, 2025
- Products distributed nationwide
- Methanol risk due to lack of testing
- No injuries reported yet
Get Alerts for Health & Personal Care Recalls
Get notified about recalls in categories you care about.
Safety Assessment
Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
POISONING
Product Classification
Product TypeHand Sanitizer
Sold At
Multiple Retailers
Product Details
Brand
Model Numbers
Lot # C2432725
Lot # C2508304
Lot # C2509304
Affected States
ALL
Report Date
October 15, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE
Related Recalls
HIGH
Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
SUCRALFATE
CGMP Deviations:
HIGH
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
Labeling: Incorrect or Missing Lot and/or Exp Date
STAQ Pharma
Labeling: Incorrect